propofol has been researched along with Carcinoma, Squamous Cell in 19 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"BACKGROUND This study was done to verify whether propofol could inhibit esophageal squamous cell carcinoma (ESCC) cell line EC9706 cell migration and invasion by targeting SOX4." | 7.85 | Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4). ( Ji, P; Li, JJ; Zhou, CL, 2017) |
"BACKGROUND This study was done to verify whether propofol could inhibit esophageal squamous cell carcinoma (ESCC) cell line EC9706 cell migration and invasion by targeting SOX4." | 3.85 | Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4). ( Ji, P; Li, JJ; Zhou, CL, 2017) |
"5‑fluorouracil (5‑FU) is a commonly used treatment for OSCC, but cells typically display resistance to the drug." | 1.72 | Propofol induces apoptosis and ameliorates 5‑fluorouracil resistance in OSCC cells by reducing the expression and secretion of amphiregulin. ( Che, PC; Chen, JC; Chen, MS; Hsieh, MJ; Lee, IN; Wu, YP; Yang, KS, 2022) |
"Propofol treatment inhibited cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT), but promoted apoptosis and induced cell cycle arrest in OSCC cells." | 1.72 | Propofol prevents the aggressive progression of oral squamous cell carcinoma via regulating circ_0005623/miR-195-5p/HOXB7 axis. ( Cao, C; Xu, Y; Zhang, X, 2022) |
"Propofol treatment significantly promoted cell migration and invasion of OSCC." | 1.56 | Propofol facilitates migration and invasion of oral squamous cell carcinoma cells by upregulating SNAI1 expression. ( Jiang, H; Li, C; Li, W; Peng, J; Wang, H; Xia, M, 2020) |
" The dosage of propofol recommended in these guidelines is, however, based on one single study." | 1.39 | [Palliative sedation in a man with oral cancer; the Royal Dutch Medical Association guidelines not always sufficient]. ( Broekhoff, FJ; Dompeling, EC; Smelt, WL; Vos-Westerman, JH; Wulffraat, ET, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 10 (52.63) | 24.3611 |
2020's | 4 (21.05) | 2.80 |
Authors | Studies |
---|---|
Yang, KS | 1 |
Che, PC | 1 |
Hsieh, MJ | 1 |
Lee, IN | 1 |
Wu, YP | 1 |
Chen, MS | 1 |
Chen, JC | 1 |
Gao, C | 1 |
Ren, C | 1 |
Liu, Z | 1 |
Zhang, L | 1 |
Tang, R | 1 |
Li, X | 1 |
Li, C | 1 |
Xia, M | 1 |
Wang, H | 1 |
Li, W | 1 |
Peng, J | 1 |
Jiang, H | 1 |
Rezniczek, GA | 1 |
Hecken, JM | 1 |
Rehman, S | 1 |
Dogan, A | 1 |
Tempfer, CB | 1 |
Hilal, Z | 1 |
Cao, C | 1 |
Zhang, X | 1 |
Xu, Y | 1 |
Conte, SC | 1 |
Spagnol, G | 1 |
Confalonieri, M | 1 |
Brizi, B | 1 |
Smelt, WL | 1 |
Wulffraat, ET | 1 |
Broekhoff, FJ | 1 |
Dompeling, EC | 1 |
Vos-Westerman, JH | 1 |
Xu, YB | 2 |
Du, QH | 1 |
Zhang, MY | 1 |
Yun, P | 1 |
He, CY | 1 |
Guo, XG | 1 |
Wang, S | 1 |
Zhuang, J | 1 |
Liu, S | 1 |
Gu, X | 1 |
Zhu, L | 1 |
Wu, G | 1 |
Zhou, H | 1 |
Song, Y | 1 |
Wu, C | 1 |
Zhou, CL | 1 |
Li, JJ | 1 |
Ji, P | 1 |
Dueñas, N | 1 |
Zaballos, M | 1 |
Zhang, LM | 1 |
Zhang, MX | 1 |
Wang, N | 1 |
Duan, XY | 1 |
Zhou, SN | 1 |
Wang, JS | 1 |
Jing, GX | 1 |
Sanz Carabaña, MP | 1 |
Nozal Mateo, B | 1 |
Ariño Irujo, J | 1 |
López Timoneda, F | 1 |
Ohno, S | 1 |
Kobayashi, K | 1 |
Uchida, S | 1 |
Amano, O | 1 |
Sakagami, H | 1 |
Nagasaka, H | 1 |
Kunimatsu, T | 1 |
Misaki, T | 1 |
Hirose, N | 1 |
Tsuboi, E | 1 |
Takahashi, I | 1 |
Ohki, H | 1 |
Oi, Y | 1 |
Matsumoto, M | 1 |
Tanaka, H | 1 |
Bley, CR | 1 |
Roos, M | 1 |
Price, J | 1 |
Ruess-Melzer, K | 1 |
Buchholz, J | 1 |
Poirier, V | 1 |
Kaser-Hotz, B | 1 |
Perera, ER | 1 |
Vidic, DM | 1 |
Zivot, J | 1 |
Leonard, IE | 1 |
Myles, PS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Large Loop Excision of the Transformation Zone (LLETZ) With Versus Without Intraoperative Application of Lugol's Iodine in Women With Cervical Dysplasia: a Prospective Randomized Trial[NCT05132114] | 216 participants (Anticipated) | Interventional | 2022-01-17 | Recruiting | |||
Large Loop Excision of the Transformatione Zone Under General Versus Local Anesthesia: a Randomized Trial.[NCT03494686] | 229 participants (Actual) | Interventional | 2018-04-03 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for propofol and Carcinoma, Squamous Cell
Article | Year |
---|---|
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Anesthetics, Inhalation; Anesthetics, Intravenous; Carcinoma, Squamous Cell; CD4-CD8 | 2016 |
17 other studies available for propofol and Carcinoma, Squamous Cell
Article | Year |
---|---|
Propofol induces apoptosis and ameliorates 5‑fluorouracil resistance in OSCC cells by reducing the expression and secretion of amphiregulin.
Topics: Amphiregulin; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferati | 2022 |
GAS5, a FoxO1-actived long noncoding RNA, promotes propofol-induced oral squamous cell carcinoma apoptosis by regulating the miR-1297-GSK3β axis.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Pr | 2019 |
Propofol facilitates migration and invasion of oral squamous cell carcinoma cells by upregulating SNAI1 expression.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Gene Expression Regulation, | 2020 |
Propofol prevents the aggressive progression of oral squamous cell carcinoma via regulating circ_0005623/miR-195-5p/HOXB7 axis.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Head and Neck Neoplasms; Homeodomain Proteins; Humans; M | 2022 |
Deep sedation versus minimal sedation during endobronchial ultrasound transbronchial needle aspiration.
Topics: Adenocarcinoma; Adjuvants, Anesthesia; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Ant | 2018 |
[Palliative sedation in a man with oral cancer; the Royal Dutch Medical Association guidelines not always sufficient].
Topics: Carcinoma, Squamous Cell; Conscious Sedation; Humans; Hypnotics and Sedatives; Male; Midazolam; Midd | 2013 |
Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Esophageal Neoplasm | 2013 |
Propofol suppresses invasion, angiogenesis and survival of EC-1 cells in vitro by regulation of S100A4 expression.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relation | 2015 |
Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4).
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Esop | 2017 |
[Anesthesia for parathyroidectomy in an elderly patient with dermatomyositis and high risk of bronchial aspiration].
Topics: Aged, 80 and over; Androstanols; Anesthesia, Intravenous; Anesthetics, Intravenous; Carcinoma, Squam | 2009 |
[Effect of low dose propofol on biological behavior of esophageal squamous cell carcinoma cell line Eca109].
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Respo | 2011 |
[Anesthetic considerations in Miller Fisher syndrome].
Topics: Anesthesia, Intravenous; Atracurium; Biopsy; Carcinoma, Squamous Cell; Epilepsies, Partial; Hernia, | 2011 |
Cytotoxicity and type of cell death induced by midazolam in human oral normal and tumor cells.
Topics: Anesthetics, Intravenous; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Diazepam; DNA Frag | 2012 |
Postoperative mental disorder following prolonged oral surgery.
Topics: Age Factors; Anesthetics, Intravenous; Blood Loss, Surgical; Carcinoma, Squamous Cell; Delirium; Fem | 2004 |
Clinical assessment of repeated propofol-associated anesthesia in cats.
Topics: Anesthesia, Intravenous; Anesthetics, Intravenous; Animals; Blood Pressure; Carcinoma, Squamous Cell | 2007 |
Carinal resection with two high-frequency jet ventilation delivery systems.
Topics: Aged; Anesthesia, Inhalation; Anesthesia, Intravenous; Carcinoma, Squamous Cell; High-Frequency Jet | 1993 |
Target-controlled intravenous anaesthesia with bispectral index monitoring for thoracotomy in a patient with severely impaired left ventricular function.
Topics: Aged; Analgesia, Epidural; Anesthesia Recovery Period; Anesthesia, Intravenous; Anesthetics, Intrave | 2000 |